首页> 外文OA文献 >PND44 Assessing Variations in Transitions in Employment in Relapsing-Remitting Multiple Sclerosis Patients Treated With Either Laquinimod, Interferon Beta 1-a or Placebo: Expoloratory Evidence From the United States Substudy of Bravo

【2h】

PND44 Assessing Variations in Transitions in Employment in Relapsing-Remitting Multiple Sclerosis Patients Treated With Either Laquinimod, Interferon Beta 1-a or Placebo: Expoloratory Evidence From the United States Substudy of Bravo

机译：PND44评估接受拉喹莫德，干扰素Beta 1-a或安慰剂治疗的复发缓解型多发性硬化症患者就业转变的变化：来自美国Bravo研究的探索性证据

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Carroll C.A.; Oleen-Burkey M.A.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study. [J] . Comi G, Abramsky O, Arbizu T, Multiple sclerosis: clinical and laboratory research . 2010,第11期

机译：复发-缓解型多发性硬化症患者的口服拉喹莫德：多中心，随机，双盲，平行组安慰剂对照研究的36周双盲有效期延长。
2. Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. [J] . Comi G, Pulizzi A, Rovaris M, The Lancet . 2008,第9630期

机译：拉喹莫德对复发缓解型多发性硬化症患者的MRI监测的疾病活动的影响：一项多中心，随机，双盲，安慰剂对照的IIb期研究。
3. Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial. [J] . Smolders J, Hupperts R, Barkhof F, Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 2011,第1a2期

机译：维生素D（3）作为复发缓解型多发性硬化症患者接受皮下干扰素beta-1a的附加治疗的有效性：II期，多中心，双盲，随机，安慰剂对照试验。
4. Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report [O] . Pietro Carrieri, Maria Petracca, Silvana Montella, 2013

机译：干扰素β1-a疗法治疗多发性硬化症患者中的零星的卟啉症角皮病：1例报告
5. PND34 Long-Term Effects on Costs and Quality Adjusted Life Years of Patients With Relapsing-Remitting Multiple Sclerosis Treated With Laquinimod: Results Based on the Allegro and Bravo Trials [O] . Lang A., Tuomari A., Kobelt G., 2012

机译：PND34对拉喹莫德治疗的复发缓解型多发性硬化症患者的费用和质量调整生命年的长期影响：基于Allegro和Bravo试验的结果

PND44 Assessing Variations in Transitions in Employment in Relapsing-Remitting Multiple Sclerosis Patients Treated With Either Laquinimod, Interferon Beta 1-a or Placebo: Expoloratory Evidence From the United States Substudy of Bravo

著录项

引文网络

相似文献

相关主题

期刊订阅